RegulatoryEconomic Times
USFDA classifies Aurobindo Pharma's US facility as 'official action indicated'
Negative-552 sources
GreyOak summary
The USFDA classified Aurobindo Pharma's Seymour facility as 'official action indicated' following an inspection from August 17-21, 2026. The regulator issued four observations, to which the company responded within the stipulated time. Aurobindo Pharma stated that this action has no impact on its financials or operations.
What it affects
- Aurobindo PharmaAUROPHARMANegative -55
USFDA classified facility as official action indicated.Rolling sentiment Negative -25
Source
Read the original at Economic TimesMore Aurobindo Pharma news
- Aurobindo Pharma shares extend losses after USFDA OAICNBC-TV18 · Regulatory ·
- Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification for Telengana facility from USFDAEconomic Times · Regulatory ·
- Aurobindo Pharma snaps 12-day winning streak after USFDA update on subsidiary's API unitCNBC-TV18 · Regulatory ·
- Helios Mid Cap Fund adds Aurobindo Pharma, increases stake in PaytmEconomic Times · Company update ·